
May 26, 2026
Engineering better cancer fighters: In conversation with Justin Milner
UNC Lineberger's Justin Milner, PhD, has emerged in recent years as a young scientist to watch in the field of cancer immunology.

May 26, 2026
UNC Lineberger's Justin Milner, PhD, has emerged in recent years as a young scientist to watch in the field of cancer immunology.

April 24, 2026
Justin Milner, PhD, and Carla Chibwesha, MD, MSc, have each received a $1 million grant from AACR. The investment will support their work aimed at improving the treatment of solid tumors, cervical cancer, lung cancer, and more.
April 19, 2026

March 19, 2026
Justin Milner, PhD, has received a grant from the V Foundation to support his research using CAR-T immunotherapy as treatment for pancreatic cancer, one of the most lethal types of cancer.

June 19, 2025
Chad Pecot, MD, and colleagues have demonstrated that a uniquely engineered drug that zeroes in on a mutated gene called KRAS G12V could potentially stop KRAS-dependent cancers in their tracks.

October 15, 2024
The NIH has awarded a five-year, $2.79 million R01 research grant to Justin Milner, PhD, to define how a druggable family of epigenetic regulators control T cell activity.
December 6, 2023

September 27, 2022
The UNC Lineberger annual scientific retreat featured faculty talks covering a range of basic, clinical/translational and population science research, as well as a poster session.